Ieq Capital LLC bought a new position in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 31,950 shares of the company’s stock, valued at approximately $809,000.
A number of other institutional investors have also added to or reduced their stakes in the company. Keybank National Association OH raised its position in Pediatrix Medical Group by 2.0% during the first quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock valued at $491,000 after purchasing an additional 458 shares in the last quarter. Gotham Asset Management LLC boosted its holdings in shares of Pediatrix Medical Group by 0.6% in the 3rd quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock worth $1,945,000 after purchasing an additional 724 shares in the last quarter. ProShare Advisors LLC increased its position in shares of Pediatrix Medical Group by 4.6% during the 4th quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock valued at $360,000 after purchasing an additional 734 shares during the last quarter. Verition Fund Management LLC raised its holdings in shares of Pediatrix Medical Group by 4.4% during the 3rd quarter. Verition Fund Management LLC now owns 25,408 shares of the company’s stock valued at $426,000 after buying an additional 1,066 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Pediatrix Medical Group by 77.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock valued at $54,000 after buying an additional 1,100 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.
Analysts Set New Price Targets
Several analysts have issued reports on MD shares. Truist Financial upped their target price on Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a report on Friday, May 8th. UBS Group upped their price objective on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and increased their target price for the company from $27.00 to $28.00 in a report on Wednesday, August 19th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $25.00 target price on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th. Seven equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $25.00.
Pediatrix Medical Group Stock Down 0.5%
NYSE MD opened at $26.81 on Friday. Pediatrix Medical Group, Inc. has a 1 year low of $15.69 and a 1 year high of $27.94. The stock has a market capitalization of $2.18 billion, a PE ratio of 12.83 and a beta of 0.66. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.32 and a quick ratio of 1.32. The business’s 50-day moving average is $26.00 and its 200 day moving average is $23.15.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. The business had revenue of $487.78 million during the quarter, compared to analyst estimates of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.Pediatrix Medical Group’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.53 EPS. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current year.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.
Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.
Read More
- Five stocks we like better than Pediatrix Medical Group
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
